NCT00341341 Impact of Lung Cancer Diagnosis on Relatives' Understanding of Genetic Risk and Receptivity to Quit Smoking Status COMPLETED Phase N/A
NCT00340847 Construction and Use of Lung Tumor Microarray for the Analysis of Gene Expression in Lung Cancer Status COMPLETED Phase N/A
NCT00340405 Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, China Status COMPLETED Phase N/A
NCT00338026 A Phase I Study of ECO-4601 in Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT00335491 Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors Status COMPLETED Phase NA
NCT00334763 Radiation Therapy, Chemotherapy, and Bevacizumab in Treating Patients With Recurrent, Unresectable or Stage III or Stage IV Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT00328588 LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy Status COMPLETED Phase PHASE2
NCT00326599 Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00324597 AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma Status UNKNOWN Phase PHASE1
NCT00323869 Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00323362 Gemcitabine and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT00322751 Concurrent Radiotherapy With Weekly Topotecan for Primary Treatment of Inoperable Localized Non-small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT00321893 Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer Status COMPLETED Phase PHASE2
NCT00315861 Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT00313690 Cancer Treatment Followed by Surgery for Early Stage Non-small Cell Lung Cancer Status WITHDRAWN Phase PHASE1/PHASE2
NCT00313599 Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00312377 ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer Status COMPLETED Phase PHASE3